Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:39 UTC |
---|
HMDB ID | HMDB0014553 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Remoxipride |
---|
Description | Remoxipride is only found in individuals that have used or taken this drug. It is an antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. [PubChem]Remoxipride acts as an antagonist at the D2 dopamine receptor. It is believed that overactivity of dopamine systems in the mesolimbic pathway may contribute to the "positive symptoms" of schizophrenia (such as delusions and hallucinations), whereas problems with dopamine function in the mesocortical pathway may be responsible for the "negative symptoms", such as avolition, flat emotional response and alogia. Therefore, by decreasing the levels of dopamine in these pathways, it is thought that remoxipride is able to reduce the symptoms of schizophrenia, particularily the "positive symptoms". |
---|
Structure | CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1 |
---|
Synonyms | Value | Source |
---|
FLA-731Roxiam | HMDB | a-33547REmoxipride | HMDB | Romoxipride | HMDB | FLA-731 | HMDB | Monohydrochloride, remoxipride | HMDB | Remoxipride hydrochloride | HMDB | Remoxipride monohydrochloride monohydrate | HMDB | (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide | HMDB | Hydrochloride anhydrous, remoxipride | HMDB | Remoxipride monohydrochloride | HMDB | Remoxipride monohydrochloride, (R)-isomer | HMDB | Remoxipride, (R)-isomer | HMDB | Remoxipride hydrochloride anhydrous | HMDB | Anhydrous, remoxipride hydrochloride | HMDB | Hydrochloride, remoxipride | HMDB | Monohydrochloride monohydrate, remoxipride | HMDB |
|
---|
Chemical Formula | C16H23BrN2O3 |
---|
Average Molecular Weight | 371.269 |
---|
Monoisotopic Molecular Weight | 370.089205259 |
---|
IUPAC Name | 3-bromo-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2,6-dimethoxybenzamide |
---|
Traditional Name | remoxipride |
---|
CAS Registry Number | 80125-14-0 |
---|
SMILES | CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC |
---|
InChI Identifier | InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1 |
---|
InChI Key | GUJRSXAPGDDABA-NSHDSACASA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dimethoxybenzenes. These are organic aromatic compounds containing a monocyclic benzene moiety carrying exactly two methoxy groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Methoxybenzenes |
---|
Direct Parent | Dimethoxybenzenes |
---|
Alternative Parents | |
---|
Substituents | - M-dimethoxybenzene
- Dimethoxybenzene
- Halobenzoic acid or derivatives
- 3-halobenzoic acid or derivatives
- Benzamide
- Benzoic acid or derivatives
- Phenoxy compound
- Anisole
- Benzoyl
- Phenol ether
- Alkyl aryl ether
- Halobenzene
- Bromobenzene
- Aryl bromide
- Aryl halide
- N-alkylpyrrolidine
- Pyrrolidine
- Amino acid or derivatives
- Carboxamide group
- Secondary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Ether
- Organonitrogen compound
- Organooxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organobromide
- Organic oxygen compound
- Organopnictogen compound
- Organohalogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.13 g/L | Not Available | LogP | 2.9 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Remoxipride,1TMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C | 2639.4 | Semi standard non polar | 33892256 | Remoxipride,1TMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C | 2523.8 | Standard non polar | 33892256 | Remoxipride,1TMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C | 3423.2 | Standard polar | 33892256 | Remoxipride,1TBDMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C(C)(C)C | 2867.1 | Semi standard non polar | 33892256 | Remoxipride,1TBDMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C(C)(C)C | 2718.8 | Standard non polar | 33892256 | Remoxipride,1TBDMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C(C)(C)C | 3492.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Remoxipride GC-MS (Non-derivatized) - 70eV, Positive | splash10-0005-9021000000-9daaecbf42f2128e1ad4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Remoxipride GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Positive-QTOF | splash10-00di-0519000000-3d2acd15eff0b46d38f4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Positive-QTOF | splash10-03di-3912000000-e22b0c0384636903281f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Positive-QTOF | splash10-01qc-9110000000-0ddfc4805450139713b1 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Negative-QTOF | splash10-014i-0029000000-cd8c03d7ed0101f27c5c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Negative-QTOF | splash10-03di-0294000000-26c857c4f2362cbb3231 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Negative-QTOF | splash10-06r6-9671000000-9edffc6cb1f1ba0b83f5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Positive-QTOF | splash10-00di-0019000000-1785aaf5dd85924ca1a4 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Positive-QTOF | splash10-00di-1329000000-f2461d27117d29c1a137 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Positive-QTOF | splash10-01oy-5790000000-c002f172028926a46b44 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Negative-QTOF | splash10-014i-0029000000-b9eb29b968cffb6427c7 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Negative-QTOF | splash10-014i-3189000000-e1209bfcec679b882747 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Negative-QTOF | splash10-0fbc-9072000000-004d419109fc829dd6cb | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|